Molekule Consulting LLC announced today the appointment of Dr. Daniel Pascheles to the position of Chief Executive Officer. Dr. Pascheles joins Molekule Consulting having a distinguished career in the biopharmaceutical industry. Most recently, he served as Vice President and Head of Global Competitive Intelligence at Merck & Co.
As Chief Executive Officer at Molekule, Dr. Pascheles will be responsible for overseeing business operations as well as shaping Molekule’s long-term growth strategy. “Dr. Pascheles is one of the most experienced, ethical and well-respected CI professionals in our industry; he is a global leader who brings expertise and exceptional vision to build our growing company,” said Molekule Consulting’s Founder and President, David Alderman.
“I am thrilled to join Molekule Consulting, a leader in delivering high-quality competitive intelligence and strategy support to the biopharmaceutical industry. I have been impressed by Molekule’s high-performance culture and talented team, which drives the exceptional success of the company. I look forward to expanding the scope of the company, the portfolio offerings and positioning us for increased global success,” said Dr. Pascheles.
Prior to joining Molekule Consulting, Dr. Pascheles was Vice President, Head of Global Competitive Intelligence at Merck and Co for twelve (12) years. He built a world-class CI department, which provided global business and competitive intelligence for Commercial and R&D activities; he also contributed to strategy development, target and candidate identification for licensing, business development and M&A activities. Dr. Pascheles previously worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for over fourteen (14) years in the following varied positions: Head of Global Competitive Intelligence, Global Marketing Director, General Manager Switzerland, European Head of Sales, Marketing Administration and Strategic Planning.
Dr. Pascheles earned his undergraduate and Ph.D. in Pharmacy at the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. He is Past-President and a current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also a member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES). He is a member of the Editorial Advisory Board of the Pharmaceutical Executive magazine, and publishes regularly in numerous trade magazines. Dr. Pascheles is also Visiting Professor at the Rey Juan Carlos University in Madrid teaching a Master Class in Competitive Intelligence.
About Molekule Consulting
Molekule Consulting LLC (“Molekule”) is a recognized global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Molekule aligns intelligence outcomes, focuses results and enables our client partners the ability to “win” in the highly dynamic and competitive biopharmaceutical space. Molekule Consulting remains a trusted partner of biopharmaceutical players today and tomorrow. For more information please visit: www.molekuleconsulting.com